Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
'Hero' who wrestled gun from Bondi shooter named as Ahmed al Ahmed- ‘We are the alternative’: Anti-Hamas Gaza militia tells BBC group is receiving international support
- \Step by step instructions to Pick the Best Material Organization for Your Home\
- Bronze Age "City of Seven Ravines" unearthed in central Asia after 3,500 years
- These 2 moon rovers used cameras and lasers to hunt for simulated water ice — and one looks like WALL-E
- Building Tough Connections: Individual Bits of knowledge on Association
- Everything you should know before booking a trip to Spain
- ‘More should be done’: UN pushes Syrian regime on justice for Druze, Alawites and minority groups
- Chinese astronauts’ return to Earth delayed over fears spaceship damaged by debris
